scholarly journals Community pharmacist participation in a practice-based research network: A report from the Medication Safety Research Network of Indiana (Rx-SafeNet)

2015 ◽  
Vol 55 (6) ◽  
pp. 649-655 ◽  
Author(s):  
Puja Patel ◽  
Heather Hemmeger ◽  
Mary Ann Kozak ◽  
Stephanie A. Gernant ◽  
Margie E. Snyder
2015 ◽  
Vol 6 (2) ◽  
Author(s):  
Mary Ann Kozak ◽  
Stephanie A. Gernant ◽  
Heather M. Hemmeger ◽  
Margie E. Snyder

Community pharmacy practice-based research networks (CP PBRNs) are a relatively new arena for pharmacists. While some lessons may be gleaned from primary care PBRNs, the experiences of CP PBRNs have much to offer the profession in terms of organization and practice. In 2012, we reported on our early experiences developing the Medication Safety Research Network of Indiana (RxSafeNet) after establishing the Network in 2010. Over the past 3 years, our CP PBRN of approximately 180 members has managed further growth by revisiting policies and procedures, maintaining CP PBRN member relationships, and preparing for financial sustainability. We look forward to furthering our CP PBRN projects in the coming years and collaborating with other CP PBRNs to enhance medication safety in Indiana and beyond.   Type: Original Research


2012 ◽  
Vol 3 (2) ◽  
Author(s):  
Margie E. Snyder ◽  
Caitlin K. Frail ◽  
Lindsey V. Seel ◽  
Kyle E. Hultgren

In 2010, the Purdue University College of Pharmacy established the Medication Safety Research Network of Indiana (Rx-SafeNet), the first practice-based research network (PBRN) in Indiana comprised solely of community pharmacies. In the development of Rx-SafeNet and through our early project experiences, we identified several "lessons learned." We share our story and what we learned in an effort to further advance the work of the greater PBRN community. We have formed the infrastructure for Rx-SafeNet, including an Executive Committee, Advisory Board, member pharmacies/site coordinators, and Project Review Team. To date, 22 community pharmacies have joined and we have recently completed data collection for the network's first project. Lessons learned during the development of Rx-SafeNet may benefit PBRNs nationally. Although community pharmacy PBRNs are not yet commonplace in the U.S., we believe their development and subsequent research efforts serve as an important avenue for investigating medication use issues.   Type: Idea Paper


2012 ◽  
Vol 3 (2) ◽  
Author(s):  
Lindsey V. Seel ◽  
Kyle E. Hultgren ◽  
Margie E. Snyder

The objective of this cross-sectional survey was to determine community pharmacy employee research project priorities and assess interest levels, barriers, and facilitators to joining a new community pharmacy practice-based research network (PBRN) and use this information in subsequent PBRN development. One hundred forty pharmacists and 40 support staff responded. The majority (72%) of respondents were somewhat interested or needed more information to determine their level of interest in joining a PBRN; 15% were very interested. While all research topics were regarded as important, dispensing errors were rated as the most important. Time constraints were considered the greatest barrier to participation. Greater knowledge of medication safety, enrichment of patient care, and improved patient and provider relationships were considered important reasons for joining a PBRN. Responses indicated favorable interest levels and project support from potential network members, though education and awareness campaigns are needed to enhance community pharmacy employee understanding of and involvement in research and PBRNs, specifically the Medication Safety Research Network of Indiana (Rx-SafeNet), a new network administered by the Purdue University College of Pharmacy. While the generalizability of survey results is limited, they were useful in determining policies and procedures of the new network. Surveying all employees involved in the future PBRN during the network development process is a unique approach to developing these types of networks in the U.S. Understanding support staff perspectives is important considering the critical role they play in project implementation and operations. Emerging PBRNs from any discipline may benefit from considering adding this step to their development.   Type: Original Research


Antibiotics ◽  
2021 ◽  
Vol 10 (3) ◽  
pp. 303
Author(s):  
Kevimy Agossa ◽  
Kadiatou Sy ◽  
Théo Mainville ◽  
Marjolaine Gosset ◽  
Sylvie Jeanne ◽  
...  

The aim of the present survey is to investigate the use of antibiotics during periodontal therapy among French dentists with a focus on exploring potential differences between various groups of practitioners. A self-administered questionnaire was distributed to different groups of practitioners including members of (i) the French Society of Periodontology and Implantology; (ii) the College of University Teachers in Periodontology and, (iii) private practitioners participating in the French general dental practice-based research network. 272 questionnaires were included in the analysis. Prescription patterns were globally in line with the current recommendations. Systemic antibiotics are most frequently used as a first-line therapy in necrotizing periodontitis (92%) and aggressive periodontitis (53.3% to 66.1%). However, malpractice still exists, including in the management of periodontal abscesses. Antibiotics are prescribed (i) less frequently for periodontal abscesses and (ii) more frequently for generalized aggressive periodontitis by members of the periodontal society and University college (p < 0.05). Amoxicillin (59.9%) and the amoxicillin + metronidazole (59.6%) combination were the most frequently prescribed molecules. Providing a high number of periodontal treatments per week, being more recently graduated, having a post-graduate certificate in periodontology and holding or having held an academic position/hospital practice were all factors associated with a better knowledge of and/or more adequate antibiotic use.


2015 ◽  
Vol 156 ◽  
pp. e145
Author(s):  
Jenna L. McCauley ◽  
Valeria V. Gordan ◽  
Joseph L. Riley ◽  
Roger B. Fillingim ◽  
Sonia K. Makhija ◽  
...  

2013 ◽  
Vol 9 (6) ◽  
pp. 719-730 ◽  
Author(s):  
David E. DeMik ◽  
Mark W. Vander Weg ◽  
Emily S. Lundt ◽  
Christopher S. Coffey ◽  
Gail Ardery ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document